{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T22:45:17Z","timestamp":1775947517801,"version":"3.50.1"},"reference-count":90,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["amjmed.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Medicine"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.amjmed.2018.07.006","type":"journal-article","created":{"date-parts":[[2018,7,26]],"date-time":"2018-07-26T12:27:35Z","timestamp":1532608055000},"page":"1332-1339.e3","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Utilization of Vasculoprotective Therapy for Peripheral Artery Disease: A Systematic Review and Meta-analysis"],"prefix":"10.1016","volume":"131","author":[{"given":"Daniel G.","family":"Hackam","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2953-2540","authenticated-orcid":false,"given":"Manav V.","family":"Vyas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.amjmed.2018.07.006_bib0001","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/j.jacc.2005.10.009","volume":"47","author":"Hirsch","year":"2006","journal-title":"J Am Coll Cardiol."},{"issue":"4","key":"10.1016\/j.amjmed.2018.07.006_bib0002","doi-asserted-by":"crossref","first-page":"264","DOI":"10.7326\/0003-4819-151-4-200908180-00135","article-title":"Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement","volume":"151","author":"Moher","year":"2009","journal-title":"Ann Intern Med."},{"issue":"1","key":"10.1016\/j.amjmed.2018.07.006_bib0003","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/2049-3258-72-39","article-title":"Metaprop: a Stata command to perform meta-analysis of binomial data","volume":"72","author":"Nyaga","year":"2014","journal-title":"Arch Public Health."},{"key":"10.1016\/j.amjmed.2018.07.006_bib0004","doi-asserted-by":"crossref","unstructured":"Tsang JLY, Mendelsohn A, Tan MKK, et al. Discordance between physicians' estimation of patient cardiovascular risk and use of evidence-based medical therapy. Am J Cardiol. 2008;102(9):1142-1145.","DOI":"10.1016\/j.amjcard.2008.06.037"},{"issue":"4","key":"10.1016\/j.amjmed.2018.07.006_bib0005","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.ejvs.2008.12.009","article-title":"In vivo confirmation of the role of statins in reducing nitric oxide and C-reactive protein levels in peripheral arterial disease","volume":"37","author":"Aguilar","year":"2009","journal-title":"Eur J Vasc Endovasc Surg."},{"issue":"3","key":"10.1016\/j.amjmed.2018.07.006_bib0006","first-page":"332","article-title":"Medical risk factor treatment in peripheral arterial disease. Need for further improvement","volume":"32","author":"Alhadad","year":"2013","journal-title":"Int Angiol."},{"issue":"3","key":"10.1016\/j.amjmed.2018.07.006_bib0007","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.jvs.2008.04.057","article-title":"Suboptimal use of statin therapy in elderly patients with atherosclerosis: a population-based study","volume":"48","author":"Al-Omran","year":"2008","journal-title":"J Vasc Surg."},{"issue":"4","key":"10.1016\/j.amjmed.2018.07.006_bib0008","doi-asserted-by":"crossref","first-page":"371","DOI":"10.4103\/0256-4947.83219","article-title":"Suboptimal use of risk reduction therapy in peripheral arterial disease patients at a major teaching hospital","volume":"31","author":"Al-Omran","year":"2011","journal-title":"Ann Saudi Med."},{"issue":"6","key":"10.1016\/j.amjmed.2018.07.006_bib0009","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1161\/CIRCINTERVENTIONS.112.975862","article-title":"The quality and impact of risk factor control in patients with stable claudication presenting for peripheral vascular interventions","volume":"5","author":"Ardati","year":"2012","journal-title":"Circ Cardiovasc Interv."},{"issue":"2","key":"10.1016\/j.amjmed.2018.07.006_bib0010","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.113.000697","article-title":"Adherence to guideline-recommended therapy is associated with decreased major adverse cardiovascular events and major adverse limb events among patients with peripheral arterial disease","volume":"3","author":"Armstrong","year":"2014","journal-title":"J Am Heart Assoc."},{"issue":"3","key":"10.1016\/j.amjmed.2018.07.006_bib0011","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1177\/1358863X15574321","article-title":"Angiotensin-converting enzyme inhibitor or angiotensin receptor blocker use is associated with reduced major adverse cardiovascular events among patients with critical limb ischemia","volume":"20","author":"Armstrong","year":"2015","journal-title":"Vasc Med."},{"issue":"1","key":"10.1016\/j.amjmed.2018.07.006_bib0012","first-page":"59","article-title":"Suboptimal treatment of risk factor for atherosclerosis in critical limb ischemia","volume":"24","author":"Barani","year":"2005","journal-title":"Int Angiol."},{"issue":"3","key":"10.1016\/j.amjmed.2018.07.006_bib0013","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1136\/jnnp-2012-303267","article-title":"Secondary prevention in patients with vascular disease. A population based study on the underuse of recommended medications","volume":"84","author":"Bejot","year":"2013","journal-title":"J Neurol Neurosurg Psychiatry."},{"issue":"2","key":"10.1016\/j.amjmed.2018.07.006_bib0014","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.avsg.2012.04.015","article-title":"Comparison of precuffed expanded polytetrafluorothylene and heparin-bonded polytetrafluorothylene graft in crural bypass","volume":"27","author":"Bellosta","year":"2013","journal-title":"Ann Vasc Surg."},{"issue":"18","key":"10.1016\/j.amjmed.2018.07.006_bib0015","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1016\/j.jacc.2017.02.064","article-title":"Underuse of prevention and lifestyle counseling in patients with peripheral artery disease","volume":"69","author":"Berger","year":"2017","journal-title":"J Am Coll Cardiol."},{"issue":"1","key":"10.1016\/j.amjmed.2018.07.006_bib0016","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/1755-5922.12100","article-title":"Cilostazol does not improve peripheral arterial disease-linked oxidative stress","volume":"33","author":"Bernal-Lopez","year":"2015","journal-title":"Cardiovasc Ther."},{"issue":"2","key":"10.1016\/j.amjmed.2018.07.006_bib0017","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1024\/0301-1526\/a000510","article-title":"High on-treatment platelet reactivity and outcomes after percutaneous endovascular procedures in patients with peripheral artery disease","volume":"45","author":"Bernlochner","year":"2016","journal-title":"Vasa."},{"issue":"2","key":"10.1016\/j.amjmed.2018.07.006_bib0018","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.avsg.2007.01.008","article-title":"Pharmacologic risk factor treatment of peripheral arterial disease is lacking and requires vascular surgeon participation","volume":"21","author":"Bianchi","year":"2007","journal-title":"Ann Vasc Surg."},{"issue":"2","key":"10.1016\/j.amjmed.2018.07.006_bib0019","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.jvs.2006.04.002","article-title":"Peripheral arterial disease versus other localizations of vascular disease: the ATTEST study","volume":"44","author":"Blacher","year":"2006","journal-title":"J Vasc Surg."},{"issue":"5","key":"10.1016\/j.amjmed.2018.07.006_bib0020","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.ejvs.2006.07.005","article-title":"Secondary prevention of arteriosclerosis in lower limb vascular amputees: a missed opportunity","volume":"32","author":"Bradley","year":"2006","journal-title":"Eur J Vasc Endovasc Surg."},{"issue":"5","key":"10.1016\/j.amjmed.2018.07.006_bib0021","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1053\/ejvs.2002.1737","article-title":"Second best medical therapy","volume":"24","author":"Burns","year":"2002","journal-title":"Eur J Vasc Endovasc Surg."},{"issue":"2","key":"10.1016\/j.amjmed.2018.07.006_bib0022","doi-asserted-by":"crossref","first-page":"e86","DOI":"10.1016\/j.atherosclerosis.2008.10.023","article-title":"Cardiovascular risk factor control and outcomes in peripheral artery disease patients in the Reduction of Atherothrombosis for Continued Health (REACH) Registry","volume":"204","author":"Cacoub","year":"2009","journal-title":"Atherosclerosis."},{"issue":"6","key":"10.1016\/j.amjmed.2018.07.006_bib0023","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.avsg.2007.07.019","article-title":"The natural history of stenoses within lower limb arterial bypass grafts using a graft surveillance program","volume":"21","author":"Carter","year":"2007","journal-title":"Ann Vasc Surg."},{"key":"10.1016\/j.amjmed.2018.07.006_bib0024","doi-asserted-by":"crossref","first-page":"185","DOI":"10.2147\/VHRM.S76651","article-title":"Adherence to guideline-recommended therapies among patients with diverse manifestations of vascular disease","volume":"11","author":"Chen","year":"2015","journal-title":"Vasc Health Risk Manag."},{"issue":"8","key":"10.1016\/j.amjmed.2018.07.006_bib0025","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/j.amjcard.2016.12.023","article-title":"Long-term comparative outcomes of patients with peripheral artery disease with and without concomitant coronary artery disease","volume":"119","author":"Chen","year":"2017","journal-title":"Am J Cardiol."},{"issue":"5","key":"10.1016\/j.amjmed.2018.07.006_bib0026","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1024\/0301-1526\/a000456","article-title":"A prospective multicentre study on the treatment of cardiovascular risk factors and claudication symptoms in patients with peripheral artery disease (the IDOMENEO study)","volume":"44","author":"Cimminiello","year":"2015","journal-title":"Vasa."},{"key":"10.1016\/j.amjmed.2018.07.006_bib0027","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2147\/VHRM.S15484","article-title":"ACE up the sleeve - are vascular patients medically optimized?","volume":"7","author":"Coveney","year":"2011","journal-title":"Vasc Health Risk Manag."},{"issue":"1","key":"10.1016\/j.amjmed.2018.07.006_bib0028","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jvs.2015.08.058","article-title":"Preoperative antiplatelet and statin treatment was not associated with reduced myocardial infarction after high-risk vascular operations in the Vascular Quality Initiative","volume":"63","author":"De Martino RR","year":"2016","journal-title":"J Vasc Surg."},{"issue":"2","key":"10.1016\/j.amjmed.2018.07.006_bib0029","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.archger.2009.09.042","article-title":"Incidence of perioperative myocardial infarction and of 2-year mortality in 577 elderly patients undergoing noncardiac vascular surgery treated with and without statins","volume":"51","author":"Desai","year":"2010","journal-title":"Arch Gerontol Geriatr."},{"issue":"3","key":"10.1016\/j.amjmed.2018.07.006_bib0030","doi-asserted-by":"crossref","first-page":"171","DOI":"10.2310\/6670.2008.00030","article-title":"Calcium channel blockers and angiotensin-converting enzyme inhibitors may be associated with altered atherosclerotic plaque size and morphology","volume":"16","author":"Eagleton","year":"2008","journal-title":"Vascular."},{"issue":"4","key":"10.1016\/j.amjmed.2018.07.006_bib0031","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/j.jvs.2015.03.066","article-title":"Association between gender and outcomes of lower extremity peripheral vascular interventions","volume":"62","author":"Ferranti","year":"2015","journal-title":"J Vasc Surg."},{"issue":"2","key":"10.1016\/j.amjmed.2018.07.006_bib0032","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1007\/s00270-015-1172-6","article-title":"High residual collagen-induced platelet reactivity predicts development of restenosis in the superficial femoral artery after percutaneous transluminal angioplasty in claudicant patients","volume":"39","author":"Gary","year":"2016","journal-title":"Cardiovasc Intervent Radiol."},{"issue":"1","key":"10.1016\/j.amjmed.2018.07.006_bib0033","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ejvs.2007.08.008","article-title":"Secondary medical prevention among Danish patients hospitalised with either peripheral arterial disease or myocardial infarction","volume":"35","author":"Gasse","year":"2008","journal-title":"Eur J Vasc Endovasc Surg."},{"issue":"2","key":"10.1016\/j.amjmed.2018.07.006_bib0034","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1177\/1708538112473977","article-title":"Aspirin usage is associated with improved prosthetic infrainguinal bypass graft patency","volume":"22","author":"Gassman","year":"2014","journal-title":"Vascular."},{"issue":"6","key":"10.1016\/j.amjmed.2018.07.006_bib0035","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/j.jvir.2014.03.004","article-title":"SUPERA interwoven nitinol Stent Outcomes in Above-Knee IntErventions (SAKE) study","volume":"25","author":"George","year":"2014","journal-title":"J Vasc Interv Radiol."},{"issue":"5","key":"10.1016\/j.amjmed.2018.07.006_bib0036","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.jacc.2005.10.052","article-title":"Statin use and functional decline in patients with and without peripheral arterial disease","volume":"47","author":"Giri","year":"2006","journal-title":"J Am Coll Cardiol."},{"issue":"4","key":"10.1016\/j.amjmed.2018.07.006_bib0037","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/j.1464-5491.2008.02402.x","article-title":"Cardiovascular risk factor management is poorer in diabetic patients with undiagnosed peripheral arterial disease than in those with known coronary heart disease or cerebrovascular disease. Results of a nationwide study in tertiary diabetes centres","volume":"25","author":"Gonzalez-Clemente","year":"2008","journal-title":"Diabet Med."},{"issue":"3","key":"10.1016\/j.amjmed.2018.07.006_bib0038","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/eci.12236","article-title":"Residual thrombin generation potential is inversely linked to the occurrence of atherothrombotic events in patients with peripheral arterial disease","volume":"44","author":"Gremmel","year":"2014","journal-title":"Eur J Clin Invest."},{"issue":"4","key":"10.1016\/j.amjmed.2018.07.006_bib0039","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.jvs.2006.05.057","article-title":"Supporting a call to action for peripheral artery disease: insights from two prospective clinical registries","volume":"44","author":"Hackam","year":"2006","journal-title":"J Vasc Surg."},{"issue":"4","key":"10.1016\/j.amjmed.2018.07.006_bib0040","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1053\/ejvs.2002.1813","article-title":"How many claudicants should be prescribed statins?","volume":"25","author":"Harrison","year":"2003","journal-title":"Eur J Vasc Endovasc Surg."},{"issue":"1","key":"10.1016\/j.amjmed.2018.07.006_bib0041","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1253\/circj.71.95","article-title":"Evaluation of medical treatment for peripheral arterial disease in Chinese high-risk patients","volume":"71","author":"Hasimu","year":"2007","journal-title":"Circ J."},{"issue":"2","key":"10.1016\/j.amjmed.2018.07.006_bib0042","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.jvs.2003.08.030","article-title":"Patients undergoing infrainguinal bypass to treat atherosclerotic vascular disease are underprescribed cardioprotective medications: effect on graft patency, limb salvage, and mortality","volume":"39","author":"Henke","year":"2004","journal-title":"J Vasc Surg."},{"issue":"3","key":"10.1016\/j.amjmed.2018.07.006_bib0043","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1253\/circj.CJ-15-1048","article-title":"Baseline characterization of Japanese peripheral arterial disease patients- analysis of Surveillance of cardiovascular Events in Antiplatelet-treated arterioSclerosis Obliterans patients in JapaN (SEASON)","volume":"80","author":"Higashi","year":"2016","journal-title":"Circ J."},{"issue":"8","key":"10.1016\/j.amjmed.2018.07.006_bib0044","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1016\/j.amjcard.2016.07.027","article-title":"Risk factor optimization and guideline-directed medical therapy in US veterans with peripheral arterial and ischemic cerebrovascular disease compared to veterans with coronary heart disease","volume":"118","author":"Hira","year":"2016","journal-title":"Am J Cardiol."},{"issue":"11","key":"10.1016\/j.amjmed.2018.07.006_bib0045","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1001\/jama.286.11.1317","article-title":"Peripheral arterial disease detection, awareness, and treatment in primary care","volume":"286","author":"Hirsch","year":"2001","journal-title":"JAMA."},{"issue":"7","key":"10.1016\/j.amjmed.2018.07.006_bib0046","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1177\/1538574412455229","article-title":"Use of angiotensin-converting enzyme inhibitors and cardiovascular outcomes following primary vascular surgery: a nationwide propensity score matched follow-up study","volume":"46","author":"Hogh","year":"2012","journal-title":"Vasc Endovascular Surg."},{"issue":"5","key":"10.1016\/j.amjmed.2018.07.006_bib0047","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1177\/2047487312449592","article-title":"Secondary medical prevention after primary vascular surgery between 1996 and 2006: a shift towards more evidence-based treatment","volume":"20","author":"Hogh","year":"2013","journal-title":"Eur J Prev Cardiol."},{"issue":"2","key":"10.1016\/j.amjmed.2018.07.006_bib0048","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.jvs.2014.02.055","article-title":"Outcomes of covered versus bare-metal balloon-expandable stents for aortoiliac occlusive disease","volume":"60","author":"Humphries","year":"2014","journal-title":"J Vasc Surg."},{"issue":"8","key":"10.1016\/j.amjmed.2018.07.006_bib0049","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1001\/jamasurg.2016.0415","article-title":"Efficacy of a guideline-recommended risk-reduction program to improve cardiovascular and limb outcomes in patients with peripheral arterial disease","volume":"151","author":"Hussain","year":"2016","journal-title":"JAMA Surg."},{"issue":"6","key":"10.1016\/j.amjmed.2018.07.006_bib0050","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1016\/j.jvs.2016.12.102","article-title":"Perioperative clopidogrel is associated with increased bleeding and blood transfusion at the time of lower extremity bypass","volume":"65","author":"Jones","year":"2017","journal-title":"J Vasc Surg."},{"issue":"3","key":"10.1016\/j.amjmed.2018.07.006_bib0051","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/s00270-013-0710-3","article-title":"Prevalence of nonresponsiveness to aspirin in patients with symptomatic peripheral arterial disease using true point of care testing","volume":"37","author":"Karnabatidis","year":"2014","journal-title":"Cardiovasc Intervent Radiol."},{"issue":"4","key":"10.1016\/j.amjmed.2018.07.006_bib0052","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.ejvs.2006.11.010","article-title":"Characteristics and treatments of patients with peripheral arterial disease referred to UK vascular clinics: results of a prospective registry","volume":"33","author":"Khan","year":"2007","journal-title":"Eur J Vasc Endovasc Surg."},{"issue":"2","key":"10.1016\/j.amjmed.2018.07.006_bib0053","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.jvs.2016.02.059","article-title":"Predictive factors for better bypass patency and limb salvage after prosthetic above-knee bypass reconstruction","volume":"64","author":"Klingelhoefer","year":"2016","journal-title":"J Vasc Surg."},{"issue":"7","key":"10.1016\/j.amjmed.2018.07.006_bib0054","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1111\/j.1742-1241.2010.02337.x","article-title":"Management of patients with peripheral arterial disease in primary care: a cross-sectional study in Germany","volume":"64","author":"Kroger","year":"2010","journal-title":"Int J Clin Pract."},{"issue":"5","key":"10.1016\/j.amjmed.2018.07.006_bib0055","first-page":"357","article-title":"Patterns of medical therapy in patients with peripheral artery disease in a tertiary care centre in Canada","volume":"23","author":"Kundhal","year":"2007","journal-title":"Can J Cardiol."},{"issue":"5","key":"10.1016\/j.amjmed.2018.07.006_bib0056","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1177\/2047487312449587","article-title":"The combined use of aspirin, a statin, and blood pressure-lowering agents (polypill components) in clinical practice in patients with vascular diseases or type 2 diabetes mellitus","volume":"20","author":"Lafeber","year":"2013","journal-title":"Eur J Prev Cardiol."},{"issue":"3","key":"10.1016\/j.amjmed.2018.07.006_bib0057","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.jvs.2015.09.059","article-title":"Attainment of low-density lipoprotein cholesterol goal after endovascular treatment is associated with reduced cardiovascular events in patients with peripheral arterial disease","volume":"63","author":"Lee","year":"2016","journal-title":"J Vasc Surg."},{"issue":"2","key":"10.1016\/j.amjmed.2018.07.006_bib0058","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.ejvs.2016.04.019","article-title":"High on-treatment platelet reactivity in peripheral arterial disease: a pilot study to find the optimal test and cut off values","volume":"52","author":"Leunissen","year":"2016","journal-title":"Eur J Vasc Endovasc Surg."},{"issue":"3","key":"10.1016\/j.amjmed.2018.07.006_bib0059","first-page":"175","article-title":"Impact of international guidelines on the management of cardiovascular risk factors in diabetic patients with peripheral arterial disease","volume":"28","author":"Margeta","year":"2009","journal-title":"Int Angiol."},{"issue":"5","key":"10.1016\/j.amjmed.2018.07.006_bib0060","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1161\/01.CIR.0000050380.64025.07","article-title":"Statin use and leg functioning in patients with and without lower-extremity peripheral arterial disease","volume":"107","author":"McDermott","year":"2003","journal-title":"Circulation."},{"issue":"2","key":"10.1016\/j.amjmed.2018.07.006_bib0061","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1007\/s11239-013-0919-7","article-title":"Effectiveness of antiplatelet therapy in atherosclerotic disease: comparing the ASA low-response prevalence in CVD, CAD and PAD","volume":"37","author":"Meves","year":"2014","journal-title":"J Thromb Thrombolysis."},{"issue":"3","key":"10.1016\/j.amjmed.2018.07.006_bib0062","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.ejim.2007.09.003","article-title":"Clinical outcome in patients with peripheral artery disease. Results from a prospective registry (FRENA)","volume":"19","author":"Monreal","year":"2008","journal-title":"Eur J Intern Med."},{"issue":"2","key":"10.1016\/j.amjmed.2018.07.006_bib0063","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1177\/153857440303700206","article-title":"Monitoring aspirin 100 mg and clopidogrel 75 mg therapy with the PFA-100 device in patients with peripheral arterial disease","volume":"37","author":"Mueller","year":"2003","journal-title":"Vasc Endovascular Surg."},{"issue":"2","key":"10.1016\/j.amjmed.2018.07.006_bib0064","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1093\/gerona\/60.2.255","article-title":"Prevalence of symptomatic peripheral arterial disease, modifiable risk factors, and appropriate use of drugs in the treatment of peripheral arterial disease in older persons seen in a university general medicine clinic","volume":"60","author":"Ness","year":"2005","journal-title":"J Gerontol A Biol Sci Med Sci."},{"issue":"1","key":"10.1016\/j.amjmed.2018.07.006_bib0065","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1161\/CIRCULATIONAHA.110.003954","article-title":"Secondary prevention and mortality in peripheral artery disease: National Health and Nutrition Examination Study, 1999 to 2004","volume":"124","author":"Pande","year":"2011","journal-title":"Circulation."},{"issue":"1","key":"10.1016\/j.amjmed.2018.07.006_bib0066","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1007\/BF03405572","article-title":"Protective vascular treatment of patients with peripheral arterial disease: guideline adherence according to year, age and gender","volume":"101","author":"Paquet","year":"2010","journal-title":"Can J Public Health."},{"issue":"6","key":"10.1016\/j.amjmed.2018.07.006_bib0067","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1111\/j.1365-2796.2007.01863.x","article-title":"Renal dysfunction predicts long-term mortality in patients with lower extremity arterial disease","volume":"262","author":"Pasqualini","year":"2007","journal-title":"J Intern Med."},{"issue":"6","key":"10.1016\/j.amjmed.2018.07.006_bib0068","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1007\/s00270-013-0577-3","article-title":"Clopidogrel responsiveness in patients undergoing peripheral angioplasty","volume":"36","author":"Pastromas","year":"2013","journal-title":"Cardiovasc Intervent Radiol."},{"issue":"3","key":"10.1016\/j.amjmed.2018.07.006_bib0069","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1080\/14017430601187751","article-title":"Diagnosis and treatment of dyslipidemia are neglected in patients with peripheral artery disease","volume":"41","author":"Poussa","year":"2007","journal-title":"Scand Cardiovasc J."},{"issue":"4","key":"10.1016\/j.amjmed.2018.07.006_bib0070","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.jvs.2009.11.062","article-title":"Fifteen years of infrapopliteal arterial reconstructions with cryopreserved venous allografts for limb salvage","volume":"51","author":"Randon","year":"2010","journal-title":"J Vasc Surg."},{"issue":"2","key":"10.1016\/j.amjmed.2018.07.006_bib0071","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1080\/00325481.2016.1144447","article-title":"Resource use and costs in high-risk symptomatic peripheral artery disease patients with diabetes and prior acute coronary syndrome: a retrospective analysis","volume":"128","author":"Reed","year":"2016","journal-title":"Postgrad Med."},{"issue":"5","key":"10.1016\/j.amjmed.2018.07.006_bib0072","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/j.jvs.2005.01.047","article-title":"Atherosclerotic risk factor control in patients with peripheral arterial disease","volume":"41","author":"Rehring","year":"2005","journal-title":"J Vasc Surg."},{"issue":"9","key":"10.1016\/j.amjmed.2018.07.006_bib0073","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.ehj.2004.02.012","article-title":"Statin therapy improves cardiovascular outcome of patients with peripheral artery disease","volume":"25","author":"Schillinger","year":"2004","journal-title":"Eur Heart J."},{"issue":"8","key":"10.1016\/j.amjmed.2018.07.006_bib0074","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1016\/j.amjcard.2014.01.405","article-title":"Comparison of lipid management in patients with coronary versus peripheral arterial disease","volume":"113","author":"Sharma","year":"2014","journal-title":"Am J Cardiol."},{"issue":"1","key":"10.1016\/j.amjmed.2018.07.006_bib0075","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/HJR.0b013e32831c1383","article-title":"Risk factor profiles and use of cardiovascular drug prevention in women and men with peripheral arterial disease","volume":"16","author":"Sigvant","year":"2009","journal-title":"Eur J Cardiovasc Prev Rehabil."},{"issue":"4","key":"10.1016\/j.amjmed.2018.07.006_bib0076","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/j.jvs.2016.03.429","article-title":"Contemporary cardiovascular risk and secondary preventive drug treatment patterns in peripheral artery disease patients undergoing revascularization","volume":"64","author":"Sigvant","year":"2016","journal-title":"J Vasc Surg."},{"issue":"4","key":"10.1016\/j.amjmed.2018.07.006_bib0077","first-page":"541","article-title":"Restenosis after stent implantation for superficial femoral artery disease in patients treated with cilostazol","volume":"79","author":"Soga","year":"2012","journal-title":"Catheter Cardiovasc Interv."},{"issue":"3","key":"10.1016\/j.amjmed.2018.07.006_bib0078","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.jvs.2011.03.003","article-title":"Clopidogrel is not associated with major bleeding complications during peripheral arterial surgery","volume":"54","author":"Stone","year":"2011","journal-title":"J Vasc Surg."},{"issue":"11","key":"10.1016\/j.amjmed.2018.07.006_bib0079","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1161\/CIRCULATIONAHA.112.108787","article-title":"Missed opportunities: despite improvement in use of cardioprotective medications among patients with lower-extremity peripheral artery disease, underuse remains","volume":"126","author":"Subherwal","year":"2012","journal-title":"Circulation."},{"issue":"1","key":"10.1016\/j.amjmed.2018.07.006_bib0080","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jvs.2014.05.093","article-title":"Statin therapy after infrainguinal bypass surgery for critical limb ischemia is associated with improved 5-year survival","volume":"61","author":"Suckow","year":"2015","journal-title":"J Vasc Surg."},{"issue":"3","key":"10.1016\/j.amjmed.2018.07.006_bib0081","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.jvir.2012.11.020","article-title":"Failure of surgical and endovascular infrainguinal and iliac procedures in the management of peripheral arterial disease using data from electronic medical records","volume":"24","author":"Sussman","year":"2013","journal-title":"J Vasc Interv Radiol."},{"issue":"1","key":"10.1016\/j.amjmed.2018.07.006_bib0082","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jvs.2007.03.022","article-title":"Prognostic value of ankle-brachial index and dobutamine stress echocardiography for cardiovascular morbidity and all-cause mortality in patients with peripheral arterial disease","volume":"46","author":"Thatipelli","year":"2007","journal-title":"J Vasc Surg."},{"issue":"4","key":"10.1016\/j.amjmed.2018.07.006_bib0083","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1007\/s12928-013-0188-6","article-title":"Efficacy of statin treatment after endovascular therapy for isolated below-the-knee disease in patients with critical limb ischemia","volume":"28","author":"Tomoi","year":"2013","journal-title":"Cardiovasc Interv Ther."},{"issue":"6","key":"10.1016\/j.amjmed.2018.07.006_bib0084","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1161\/CIRCINTERVENTIONS.113.000274","article-title":"Preoperative statins and limb salvage after lower extremity revascularization in the Medicare population","volume":"6","author":"Vogel","year":"2013","journal-title":"Circ Cardiovasc Interv."},{"issue":"10","key":"10.1016\/j.amjmed.2018.07.006_bib0085","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1002\/pds.2195","article-title":"Drug utilization according to reason for prescribing: a pharmacoepidemiologic method based on an indication hierarchy","volume":"21","author":"Wallach","year":"2012","journal-title":"Pharmacoepidemiol Drug Saf."},{"issue":"3","key":"10.1016\/j.amjmed.2018.07.006_bib0086","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.ijcard.2004.10.030","article-title":"The effect of preoperative statin therapy on cardiovascular outcomes in patients undergoing infrainguinal vascular surgery","volume":"104","author":"Ward","year":"2005","journal-title":"Int J Cardiol."},{"issue":"7","key":"10.1016\/j.amjmed.2018.07.006_bib0087","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.jacc.2013.09.073","article-title":"Association between statin medications and mortality, major adverse cardiovascular event, and amputation-free survival in patients with critical limb ischemia","volume":"63","author":"Westin","year":"2014","journal-title":"J Am Coll Cardiol."},{"issue":"2","key":"10.1016\/j.amjmed.2018.07.006_bib0088","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1177\/0003319715583429","article-title":"Management and outcomes among Chinese hospitalized patients with established cardiovascular disease or multiple risk factors","volume":"67","author":"Yang","year":"2016","journal-title":"Angiology."},{"issue":"3","key":"10.1016\/j.amjmed.2018.07.006_bib0089","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1177\/000331970505600307","article-title":"Risk modification in patients with peripheral arterial disease: a retrospective survey","volume":"56","author":"Youssef","year":"2005","journal-title":"Angiology."},{"issue":"4","key":"10.1016\/j.amjmed.2018.07.006_bib0090","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1590\/S1807-59322009000400010","article-title":"Profile of cardiovascular risk factors and mortality in patients with symptomatic peripheral arterial disease","volume":"64","author":"Zanati","year":"2009","journal-title":"Clinics (Sao Paulo)."}],"container-title":["The American Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000293431830679X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000293431830679X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T09:14:59Z","timestamp":1757582099000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000293431830679X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":90,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["S000293431830679X"],"URL":"https:\/\/doi.org\/10.1016\/j.amjmed.2018.07.006","relation":{},"ISSN":["0002-9343"],"issn-type":[{"value":"0002-9343","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Utilization of Vasculoprotective Therapy for Peripheral Artery Disease: A Systematic Review and Meta-analysis","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjmed.2018.07.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}